Pathway enrichment analysis revealed that in a subset of lymphoma cell lines of p53 wild-type genotype, GSK3326595 or GSK3203591 treatment lead to a significant upregulation of genes involved in the p53 pathway (Fig. 3D, except JVM-2). Here, TP53 is linked to lymphoma.